NCT07204249View on ClinicalTrials.gov

Glutide for Ending Methamphetamine

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

January 15, 2026

Primary Completion Date

February 15, 2030

Study Completion Date

February 15, 2030

Conditions

Methamphetamine-dependence

Interventions

DRUG

Semaglutide

Semaglutide

DRUG

Placebo

Placebo

All Listed Sponsors

lead

San Francisco Department of Public Health

OTHER_GOV